• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 区的肝星状细胞在肝纤维化中发生毛细血管化,而不是肌成纤维细胞形成。

Hepatic stellate cells in zone 1 engage in capillarization rather than myofibroblast formation in murine liver fibrosis.

机构信息

Physiologisches Institut, Julius-Maximilians-Universität Würzburg, 97070, Würzburg, Germany.

出版信息

Sci Rep. 2024 Aug 13;14(1):18840. doi: 10.1038/s41598-024-69898-z.

DOI:10.1038/s41598-024-69898-z
PMID:39138336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11322391/
Abstract

The combination of lineage tracing and immunohistochemistry has helped to identify subpopulations and fate of hepatic stellate cells (HSC) in murine liver. HSC are sinusoidal pericytes that act as myofibroblast precursors after liver injury. Single cell RNA sequencing approaches have recently helped to differentiate central and portal HSC. A specific Cre line to lineage trace portal HSC has not yet been described. We used three Cre lines (Lrat-Cre, PDGFRβ-CreER and SMMHC-CreER) known to label mesenchymal cells including HSC in combination with a tdTomato-expressing reporter. All three Cre lines labeled populations of HSC as well as smooth muscle cells (SMC). Using the SMMHC-CreER, we identified a subtype of HSC in the periportal area of the hepatic lobule (termed zone 1-HSC). We lineage traced tdTomato-expressing zone 1-HSC over 1 year, described fibrotic behavior in two fibrosis models and investigated their possible role during fibrosis. This HSC subtype resides in zone 1 under healthy conditions; however, zonation is disrupted in preclinical models of liver fibrosis (CCl and MASH). Zone 1-HSC do not transform into αSMA-expressing myofibroblasts. Rather, they participate in sinusoidal capillarization. We describe a novel subtype of HSC restricted to zone 1 under physiological conditions and its possible function after liver injury. In contrast to the accepted notion, this HSC subtype does not transform into αSMA-positive myofibroblasts; rather, zone 1-HSC adopt properties of capillary pericytes, thereby participating in sinusoidal capillarization.

摘要

谱系追踪和免疫组织化学的结合有助于鉴定肝星状细胞(HSC)在小鼠肝脏中的亚群和命运。HSC 是窦周细胞,在肝损伤后作为肌成纤维细胞前体发挥作用。单细胞 RNA 测序方法最近有助于区分中央型和门脉型 HSC。尚未描述用于谱系追踪门脉型 HSC 的特定 Cre 系。我们使用了三种已知可标记包括 HSC 在内的间充质细胞的 Cre 系(Lrat-Cre、PDGFRβ-CreER 和 SMMHC-CreER),并结合 tdTomato 表达报告基因。这三种 Cre 系都标记了 HSC 和平滑肌细胞(SMC)的群体。使用 SMMHC-CreER,我们在肝小叶的门脉周围区域鉴定出一种 HSC 亚型(称为 1 区 HSC)。我们对表达 tdTomato 的 1 区 HSC 进行了超过 1 年的谱系追踪,在两种纤维化模型中描述了其纤维化行为,并研究了它们在纤维化过程中的可能作用。这种 HSC 亚型在健康条件下位于 1 区;然而,在肝纤维化的临床前模型(CCl 和 MASH)中,分区被打乱。1 区 HSC 不会转化为表达 αSMA 的肌成纤维细胞。相反,它们参与了窦状隙毛细血管化。我们描述了一种在生理条件下仅限于 1 区的新型 HSC 亚型及其在肝损伤后的可能功能。与公认的观点相反,这种 HSC 亚型不会转化为 αSMA 阳性肌成纤维细胞;相反,1 区 HSC 采用毛细血管周细胞的特性,从而参与窦状隙毛细血管化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/d41b89d877ef/41598_2024_69898_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/aca38a558386/41598_2024_69898_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/50f1559011b5/41598_2024_69898_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/c14d5996f302/41598_2024_69898_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/2898a77208a9/41598_2024_69898_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/4eefcf93f2a6/41598_2024_69898_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/e2e2d0c79196/41598_2024_69898_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/7248dd5ac77c/41598_2024_69898_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/d41b89d877ef/41598_2024_69898_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/aca38a558386/41598_2024_69898_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/50f1559011b5/41598_2024_69898_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/c14d5996f302/41598_2024_69898_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/2898a77208a9/41598_2024_69898_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/4eefcf93f2a6/41598_2024_69898_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/e2e2d0c79196/41598_2024_69898_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/7248dd5ac77c/41598_2024_69898_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/11322391/d41b89d877ef/41598_2024_69898_Fig8_HTML.jpg

相似文献

1
Hepatic stellate cells in zone 1 engage in capillarization rather than myofibroblast formation in murine liver fibrosis.1 区的肝星状细胞在肝纤维化中发生毛细血管化,而不是肌成纤维细胞形成。
Sci Rep. 2024 Aug 13;14(1):18840. doi: 10.1038/s41598-024-69898-z.
2
Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.在小鼠肝纤维化消退过程中肝星状细胞的失活。
Gastroenterology. 2012 Oct;143(4):1073-83.e22. doi: 10.1053/j.gastro.2012.06.036. Epub 2012 Jun 27.
3
P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.P300 乙酰转移酶介导肝星状细胞硬度诱导激活为促肿瘤肌成纤维细胞。
Gastroenterology. 2018 Jun;154(8):2209-2221.e14. doi: 10.1053/j.gastro.2018.02.015. Epub 2018 Feb 15.
4
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.刺猬-YAP 信号通路调控谷氨酰胺代谢以控制肝星状细胞的激活。
Gastroenterology. 2018 Apr;154(5):1465-1479.e13. doi: 10.1053/j.gastro.2017.12.022. Epub 2018 Jan 3.
5
An inducible model for genetic manipulation and fate-tracing of PDGFRβ-expressing fibrogenic cells in the liver.一种诱导型模型,用于遗传操作和肝内 PDGFRβ 表达纤维生成细胞的命运追踪。
Sci Rep. 2023 May 5;13(1):7322. doi: 10.1038/s41598-023-34353-y.
6
NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice.NLR 家族包含 Pyrin 结构域的 3 炎性小体在肝星状细胞中的激活可诱导小鼠肝纤维化。
Hepatology. 2019 Feb;69(2):845-859. doi: 10.1002/hep.30252. Epub 2019 Jan 3.
7
Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury.肝星状细胞在肝脏纤维化中的异质性:肝损伤单细胞转录组分析的见解。
Cells. 2021 Aug 19;10(8):2129. doi: 10.3390/cells10082129.
8
NO-sensitive guanylyl cyclase discriminates pericyte-derived interstitial from intra-alveolar myofibroblasts in murine pulmonary fibrosis.NO-敏感型鸟苷酸环化酶可区分小鼠肺纤维化中来源于周细胞的细胞间液和肺泡内肌成纤维细胞。
Respir Res. 2023 Jun 22;24(1):167. doi: 10.1186/s12931-023-02479-2.
9
Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis.组蛋白甲基转移酶 Suv39h1 调控肝星状细胞活化,可作为肝纤维化的治疗靶点。
Gut. 2024 Apr 5;73(5):810-824. doi: 10.1136/gutjnl-2023-329671.
10
Murine junctional adhesion molecules JAM-B and JAM-C mediate endothelial and stellate cell interactions during hepatic fibrosis.小鼠连接粘附分子JAM-B和JAM-C在肝纤维化过程中介导内皮细胞与星状细胞的相互作用。
Cell Adh Migr. 2016 Jul 3;10(4):419-33. doi: 10.1080/19336918.2016.1178448. Epub 2016 Apr 25.

引用本文的文献

1
Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis.肝星状细胞与肝脏微环境之间的动态串扰:肝脏纤维化调控中的多细胞相互作用
Front Cell Dev Biol. 2025 Jul 21;13:1635763. doi: 10.3389/fcell.2025.1635763. eCollection 2025.
2
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的抗纤维化治疗
JHEP Rep. 2025 Apr 11;7(8):101421. doi: 10.1016/j.jhepr.2025.101421. eCollection 2025 Aug.
3
Bidirectional Role of Pericytes in Ischemic Stroke.

本文引用的文献

1
NO-sensitive guanylyl cyclase discriminates pericyte-derived interstitial from intra-alveolar myofibroblasts in murine pulmonary fibrosis.NO-敏感型鸟苷酸环化酶可区分小鼠肺纤维化中来源于周细胞的细胞间液和肺泡内肌成纤维细胞。
Respir Res. 2023 Jun 22;24(1):167. doi: 10.1186/s12931-023-02479-2.
2
Liver zonation, revisited.肝分区,再探。
Hepatology. 2022 Oct;76(4):1219-1230. doi: 10.1002/hep.32408. Epub 2022 Mar 6.
3
Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity.对人类肝脏进行单细胞RNA测序揭示了肝星状细胞的异质性。
周细胞在缺血性卒中中的双向作用
Brain Sci. 2025 Jun 4;15(6):605. doi: 10.3390/brainsci15060605.
4
Targeting Hepatic Stellate Cells for the Prevention and Treatment of Liver Cirrhosis and Hepatocellular Carcinoma: Strategies and Clinical Translation.靶向肝星状细胞预防和治疗肝硬化及肝细胞癌:策略与临床转化
Pharmaceuticals (Basel). 2025 Mar 31;18(4):507. doi: 10.3390/ph18040507.
5
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer.肝癌中肝星状细胞的功能异质性
Semin Liver Dis. 2025 Mar;45(1):33-51. doi: 10.1055/a-2551-0724. Epub 2025 Mar 5.
6
Advances in the understanding of the role and mechanism of action of PFKFB3‑mediated glycolysis in liver fibrosis (Review).PFKFB3 介导的糖酵解在肝纤维化作用和机制研究进展(综述)。
Int J Mol Med. 2024 Dec;54(6). doi: 10.3892/ijmm.2024.5429. Epub 2024 Sep 20.
JHEP Rep. 2021 Mar 21;3(3):100278. doi: 10.1016/j.jhepr.2021.100278. eCollection 2021 Jun.
4
Perivenous Stellate Cells Are the Main Source of Myofibroblasts and Cancer-Associated Fibroblasts Formed After Chronic Liver Injuries.慢性肝损伤后形成的肌成纤维细胞和癌相关成纤维细胞主要来源于肝窦周星形细胞。
Hepatology. 2021 Sep;74(3):1578-1594. doi: 10.1002/hep.31848.
5
Parallel Lineage-Tracing Studies Establish Fibroblasts as the Prevailing In Vivo Adipocyte Progenitor.平行谱系追踪研究确立了成纤维细胞作为体内脂肪细胞前体的主流地位。
Cell Rep. 2020 Jan 14;30(2):571-582.e2. doi: 10.1016/j.celrep.2019.12.046.
6
Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis.单细胞转录组学揭示肝纤维化过程中间质功能的分区。
Cell Rep. 2019 Nov 12;29(7):1832-1847.e8. doi: 10.1016/j.celrep.2019.10.024.
7
The Hepatic Central Vein: Structure, Fibrosis, and Role in Liver Biology.肝中央静脉:结构、纤维化及其在肝脏生物学中的作用。
Anat Rec (Hoboken). 2020 Jul;303(7):1747-1767. doi: 10.1002/ar.24273. Epub 2019 Oct 18.
8
Dynamic Remodeling of Pericytes In Vivo Maintains Capillary Coverage in the Adult Mouse Brain.血管周细胞在体动态重塑维持成年小鼠大脑毛细血管覆盖。
Cell Rep. 2018 Jan 2;22(1):8-16. doi: 10.1016/j.celrep.2017.12.016.
9
Hepatic stellate cells as key target in liver fibrosis.肝星状细胞作为肝纤维化的关键靶点。
Adv Drug Deliv Rev. 2017 Nov 1;121:27-42. doi: 10.1016/j.addr.2017.05.007. Epub 2017 May 12.
10
Mechanisms of hepatic stellate cell activation.肝星状细胞激活的机制。
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411. doi: 10.1038/nrgastro.2017.38. Epub 2017 May 10.